Urikal Oral Solution is a medicinal formulation containing Potassium Citrate and Citric Acid, designed to alkalinize urine and address various urinary tract and kidney-related conditions. It is commonly used to relieve discomfort associated with urinary tract infections (UTIs), prevent the formation of kidney stones, manage acidosis caused by kidney diseases, and as an adjunct in the treatment of gout when used with uricosuric agents. The solution is palatable and well-tolerated, even during prolonged use, without interfering with gastric digestion. Urikal is manufactured by Incepta Pharmaceuticals Ltd., a reputable pharmaceutical company in Bangladesh.